InforSense, Ltd. provides enterprise business intelligence and reporting software. Its products include core technology, such as InforSense Platform that enables organizations to integrate, automate, and visualize data sources, information, and analysis processes to deliver predictive insights. Its core technology products also include VisualSense, advanced analytics, reporting, TextSense, document explore, automation, workflow library, In-Oracle edition, Siebel edition, and virtual machine. The company also provides Life Science Applications products, such as ClinicalSense, a clinical research software application for cohort identification for clinical researchers; GenSense that enables the analysis of data from the latest generation of high-throughput genotyping platforms; Translational Research solution that provides a framework to integrate and analyze clinical, patient specimen, and experimental data for clinical translational research; BioSense that provides an interactive analytics environment for designing and executing bioinformatics solutions ranging from sequence analysis to microarray informatics and remote database annotation; and ChemSense that provides a vendor-neutral environment for designing and executing cheminformatics solutions. In addition, it offers business intelligence products and solutions, such as asset management, credit risk, CRM analytics, operational risk, and Siebel edition datasheet solutions. Further, the company provides consulting, workshop, and training services. The company serves pharmaceutical, biotechnology, consumer goods, healthcare, financial services, manufacturing, and communications companies. It has operations in the United Kingdom, the United States, Germany, and Japan. InforSense, Ltd. was founded in 1999 and is based in London, the United Kingdom with additional offices in Cambridge, Massachusetts; and Shanghai, China. As of June 2009, InforSense Ltd. operates as a subsidiary of ID Business Solutions Ltd.